EMA Defers U.S. GMP Inspections Pending November Activation of Mutual Agreement

Drug GMP Report
The European Medicines Agency is putting off plans for GMP inspections in the U.S. when possible, an EMA spokesperson confirmed, in anticipation of the November launch of a mutual agreement between the EU and U.S.

To View This Article:


Subscribe To Drug GMP Report